Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Reexamination Certificate
2011-04-05
2011-04-05
Canella, Karen A (Department: 1643)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
C435S344100, C435S346000, C530S388300, C530S388850
Reexamination Certificate
active
07919314
ABSTRACT:
Provided is a use of a recombinant chimaeric protein as an immunogen in a process for producing a monoclonal antibody, wherein the recombinant chimaeric protein is assembled into a virus-like particles, and includes a foreign protein or peptide or a fragment thereof.
REFERENCES:
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 5437951 (1995-08-01), Lowy et al.
patent: 5723287 (1998-03-01), Russell et al.
patent: 6150508 (2000-11-01), Murphy et al.
patent: 6719978 (2004-04-01), Schiller et al.
patent: 2003/0099668 (2003-05-01), Bachmann et al.
patent: 0330661 (1989-09-01), None
patent: 1030923 (2000-08-01), None
patent: WO00/23955 (2000-04-01), None
patent: WO03/106616 (2003-12-01), None
patent: WO2006/045849 (2006-05-01), None
Price et al (Tumour Biology, 1998, vol. 19 (supplement), pp. 1-20).
Campbell (Monoclonal Antibody Technology, 1984, pp. 1-32).
Clark (Protein Engineering of Antibody Molecules for Prophylactic and Therapeutic Applications in Man, 1993, pp. 4-5).
Adams, S. E., et al., “Expression vectors for the construction of hybrid Ty-VLPs,” Mol. Biotechnol. 1994;1(2):125-135.
Bashir, I., et al., “Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier,” Virchows Arch. 1998;432:279-287.
Bhatnagar, P. K., et al., “Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant,” Proc. Natl. Acad. Sci. USA 1982;79:4400-4404.
Fitzmaurice, C. J., et al., “The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants,” Vaccine 1996;14)6):553-560.
Gedvilaite, A., et al., “Formation of Immunogenic Virus-like Particles by Inserting Epitopes into Surface-Exposed Regions of Hamster Polyomavirus Major Capsid Protein,” Virology 2000;273(1):21-35.
Gedvilaite, A., et al., “Segments of Puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice,” Viral Immunol. 2004;17(1):51-68.
Gold, D. V., et al., “Monoclonal Antibody G47 Engineered to be Reactive with Colorectal Tumor Mucin,” Hybrid. Hybridomics 2001;20(5):343-350.
Huhle, G., et al., “Comparison of Three Heparin Bovine Serum Albumin Binding Methods for Production of Antiheparin Antibodies,” Semin. Thromb. Hemost. 1994;20(2):193-204.
Jurzak, M., et al., “Monoclonal antibodies against different epitopes of peptide hormones: Use of photoreactive analogues in studies on vasopressin,” Eur. J. Biochem. 1990;190:45-52.
Kohler, G., et al., “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature 1975:256(5517):495-497.
Morii, M., et al., “Antigenic Characterization of Hantaan and Seoul Virus Nucleocapsid Proteins Expressed by Recombinant Baculovirus: Application of a Truncated Protein, Lacking an Antigenic Region Common to the Two Viruses, as a Sereotyping Antigen,” J. Clin. Microbiol. 1998;36(9):2514-2521.
Okumura, M., et al., “Epitope analysis of monoclonal antibody E5/G6, which binds to a linear epitope in the nucleocapsid protein of hantaviruses,” Arch. Virol. 2004;149:2427-2434.
Paknejad, M., et al., “Production of monoclonal antibody, PR81, recognizing the tandem repeat region of MUC1 mucin,” Hybrid. Hybridomics 2003:22(3):153-158.
Ruo, S. L., et al., “Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala,” Arch. Virol. 1991;119:1-11.
Sasnauskas, K., et al., “Yeast Cells Allow High-Level Expression and Formation of Polyomavirus-Like Particles,” Biol. Chem. 1999;380:381-386.
Sasnauskas, K., et al., “Generation of Recombinant Virus-Like Particles of Human and Non-Human Polyomaviruses in Yeast Saccharomyces cerevisiae,” Intervirology 2002;45:308-317.
Shin, C. Y., et al., “Production and Characterization of Monoclonal Antibodies Against Human Airway Mucins,” Hybridoma 1999;18(5):457-463.
Voronkova, T., et al., “Chimeric Bacteriophage fr Virus-Like Particles Harboring the Immunodominant C-Terminal Region of Hamster Polymavirus VP1 Induce a Strong VP1-Specific Antibody Response in Rabbits and Mice,” Viral Immunol. 2002;15(4):627-643.
Yoshimatsu, K., et al., “Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies,” J. Gen. Virol. 1996;77:695-704.
Xing, P-X, et al., “Second Generation Anti-Nuci Peptide Monoclonal Antibodies,” Cancer Research, American Association for Cancer Research, Baltimore, MD, US, vol. 52, No. 8, Apr. 15, 1992.
Zvirbliene, A., et al., “Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles,” J. Immunol. Methods 2006;311(1-2):57-70.
International Search Report for PCT Patent App. No. PCT/EP2006/003420 (Oct. 24, 2006).
Gedvilaite Alma
Sasnauskas Kestutis
Ulrich Rainer
Zvirbliene Aurelija
Biotechnologijos Institutas
Canella Karen A
Cermak Shelly Guest
Cermak Nakajima LLP
LandOfFree
Process for the production of monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the production of monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the production of monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699637